Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa
Sunday, March 17, 2013 - 08:01
in Health & Medicine
Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer patients.